# Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus

> **NCT01029704** · PHASE2 · COMPLETED · sponsor: **Theracos** · enrollment: 151 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** EGT0001442
- **DRUG:** Placebo capsules to match EGT0001442

## Key facts

- **NCT ID:** NCT01029704
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01029704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01029704, "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01029704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*